Table 2.
Diagnostic criteria adapted from the HLH-2004 trial.
Molecular identification of an HLH-associated gene mutation (e.g. PRF1, UNC13D, STX11, STXBP2, Rab27A, SH2D1A, BIRC4, LYST, ITK, SLC7A7, XMEN, and HPS) |
OR |
Five of the following eight findings: |
1. Fever ≥ 38.5℃ |
2. Splenomegaly |
3. Peripheral blood cytopenia |
4. Hypertriglyceridemia (fasting triglycerides >265 mg/dL) and/or hypofibrinogenaemia (fibrinogen < 150 mg/dL) |
5. Haemophagocytosis in bone marrow, spleen, lymph node or liver |
6. Low or absent NK cell activity |
7. Ferritin > 500 ng/mL |
8. Elevated soluble CD25 (soluble IL-2 receptor alpha) two standard deviations above age-adjusted laboratory-specific norms |
Note: Adapted from Jordan et al.1